OCGN (Ocugen) Cyclically Adjusted PB Ratio: (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCGN Ocugen Inc OCGN
20 GF Score
Price $1.28
GF Value $0.80
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ocugen  (NAS:OCGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ocugen Cyclically Adjusted PB Ratio Related Terms


Ocugen Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Ocugen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen Cyclically Adjusted PB Ratio Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.03 0.03 0.50

Ocugen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.23 0.50 0.00 0.00

OCGN vs EVMN, PBYI, LRMR: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Ocugen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ocugen's Cyclically Adjusted PB Ratio falls into.


OCGN
20GF Score
Ocugen Inc OCGN
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ocugen's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Ocugen's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.049/333.9520*333.9520
=-0.049

Current CPI (Jun. 2026) = 333.9520.

Ocugen Quarterly Data

Book Value per Share CPI Adj_Book
201609 15.230 241.428 21.067
201612 39.439 241.432 54.553
201703 18.894 243.801 25.880
201706 2.173 244.955 2.962
201709 -12.666 246.819 -17.137
201712 -27.483 246.524 -37.230
201803 -41.987 249.554 -56.187
201806 -48.829 251.989 -64.711
201809 -16.597 252.439 -21.956
201812 -0.443 251.233 -0.589
201903 -3.508 254.202 -4.609
201906 -5.536 256.143 -7.218
201909 -1.307 256.759 -1.700
201912 0.209 256.974 0.272
202003 0.139 258.115 0.180
202006 0.108 257.797 0.140
202009 0.089 260.280 0.114
202012 0.117 260.474 0.150
202103 0.247 264.877 0.311
202106 0.586 271.696 0.720
202109 0.538 274.310 0.655
202112 0.481 278.802 0.576
202203 0.608 287.504 0.706
202206 0.528 296.311 0.595
202209 0.440 296.808 0.495
202212 0.334 296.797 0.376
202303 0.335 301.836 0.371
202306 0.274 305.109 0.300
202309 0.228 307.789 0.247
202312 0.158 306.746 0.172
202403 0.118 312.332 0.126
202406 0.066 314.175 0.070
202409 0.140 315.301 0.148
202412 0.102 315.605 0.108
202503 0.054 319.799 0.056
202506 0.010 322.561 0.010
202509 0.011 324.800 0.011
202512 -0.039 324.054 -0.040
202603 0.017 330.213 0.017
202606 -0.049 333.952 -0.049

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ocugen (OCGN) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of $1.28 is trading 60% above its estimated GF Value™ of $0.80. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for OCGN:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.80 vs. price of $1.28 (60% above fair value)
  • GF Score™: 20/100 with 4 warning signs

No single metric tells the full story. See the OCGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ocugen Business Description

Other Exchanges OCGN:Mexico2H51:Germany
Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
20GF Score

Get the complete analysis for OCGN

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.28
Price
$0.80
GF Value